Core Insights - Biotricity Inc. has achieved positive free cash flow for the first time in its history, marking a significant milestone towards profitability [3][4] - The company reported a positive free cash flow of 355,016forthequarterendedSeptember30,2024,anotableimprovementfromnegative725,567 in the previous quarter and negative 1.6millioninthesamequarterlastyear[5][6]−Freecashflowpershareforthequarterwas0.016, compared to negative 0.186inthecorrespondingquarterofthepriorfiscalyear[5]FinancialPerformance−ThenetcashusedinoperatingactivitiesforthequarterendedSeptember30,2024,was(397,059), a decrease from (1,494,240)inthepreviousquarterand(2,390,036) in the same quarter last year [6] - Interest expense for the quarter was 752,075,slightlydownfrom768,673 in the previous quarter and comparable to $753,268 in the same quarter last year [6] - The weighted average number of common shares outstanding increased to 22,493,626 for the quarter ended September 30, 2024, from 14,169,441 in the previous quarter and 8,795,742 in the same quarter last year [6] Strategic Outlook - The company plans to accelerate new product launches anticipated in FY25, which is expected to bring it closer to long-term profitability and sustainability [4] - Management emphasizes the importance of free cash flow as a key metric for assessing progress towards profitability [4][5]